Effectiveness of INTEGRA (Glucose Telemonitoring) on Quality of Life and Medication Adherence in Type 2 Diabetes at Puskesmas Cilacap Tengah I

Lina Nur’aini (Magister Keperawatan, Ilmu Keperawatan dan Kesehatan, Univesitas Karya Husada Semarang, Indonesia)
Dwi Indah Iswanti (Magister Keperawatan, Ilmu Keperawatan dan Kesehatan, Univesitas Karya Husada Semarang, Indonesia)
Sonhaji Sonhaji (Magister Keperawatan, Ilmu Keperawatan dan Kesehatan, Univesitas Karya Husada Semarang, Indonesia)

Media of Health Research
Vol. 4 No. 3 (2026): Media of Health Research, August 2026

Type 2 Diabetes Mellitus requires continuous management. Health-Related Quality of Life (HRQoL) and medication adherence are important indicators of therapy success that are often affected by a decline in ongoing understanding. Analyze the effect of INTEGRA (Blood Glucose Telemonitoring Intervention) on HRQoL and medication adherence of Type 2 Diabetes Mellitus patients at the Cilacap Tengah I Community Health Center. This quasi-experimental pretest-posttest study with a control group involved 138 respondents (69 intervention, 69 control) selected by purposive sampling and simple randomization. The intervention group received the INTEGRA program for 12 weeks; the control group received standard care. HRQoL was measured using the WHOQOL-BREF and complemented by the Summary of Diabetes Self-Care Activity (SDSCA). Analysis used Mann-Whitney, Wilcoxon, and ANOVA. The intervention group showed an increase in SDSCA scores; the control did not change significantly. The WHOQOL-BREF intervention score increased, whereas the control remained stable. ANOVA showed INTEGRA increased confounding variables. INTEGRA effectively improves HRQoL and treatment adherence in patients with Type 2 Diabetes Mellitus. The program is recommended for services in primary health facilities.